Detection of HPV-induced cervical (pre) neoplastic lesions: A tissue microarray (TMA) study

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 5, 2008, Pages 422-432

  Arafa, Mohammad ^a,b   Boniver, Jacques ^a   Delvenne, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Biomarkers; Cervix; Intraepithelial lesions; Neoplasia

Indexed keywords

BIOLOGICAL MARKER; CAPSID PROTEIN L1; INVOLUCRIN; KI 67 ANTIGEN; PROTEIN P16; VIRUS DNA; VIRUS PROTEIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; PRECANCER; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 55949116137     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318166fd42     Document Type: Article

References (35)

1. Volgareva G, Zavalishina L, Andreeva Y, et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer. 2004;4:58. (Pubitemid 40180296)
2. Kalof AN, Evans MF, Simmons-Arnold L, et al. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol. 2005;29:674-679. (Pubitemid 40577879)
3. Baak JP, Kruse AJ, Robboy SJ, et al. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol. 2006;59:1017-1028.
4. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55-F78.
5. Kruse AJ, Baak JP, Janssen EA, et al. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables. J Pathol. 2003;199:462-670.
6. Fujii T, Masumoto N, Saito M, et al. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn Mol Pathol. 2005;14:103-108. (Pubitemid 40734078)
7. Kong CS, Balzer BL, Troxell ML, et al. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol. 2007;31:33-43.
8. Nam EJ, Kim JW, Kim SW, et al. The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol. 2007;104:207-211. (Pubitemid 46054131)
9. Melsheimer P, Kaul S, Dobeck S, et al. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol. 2003;47:124-128. (Pubitemid 36367917)
10. Lorenzato M, Caudroy S, Bronner C, et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high grade lesions? Hum Pathol. 2005;36:1101-1107.
11. Kalof AN, Cooper K. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 2006;13:190-194.
12. Nair SA, Nair MB, Jayaprakash PG, et al. Involucrin and tumor progression in the uterine cervix. Pathobiology. 1996;64:333-338.
13. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847. (Pubitemid 28331029)
14. Tawfik El-Mansi M, Williams AR. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer. 2006;16:1225-1233. (Pubitemid 43886750)
15. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791-795.
16. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996;34:745-747. (Pubitemid 26065812)
17. Delvenne P, Fontaine MA, Delvenne C, et al. Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. Mod Pathol. 1994;7: 113-119.
18. Kristiansen E, Jenkins A, Holm R. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol. 1994;47:253-256. (Pubitemid 24120690)
19. Backe J, Roos T, Mulfinger L, et al. Prevalence of human papillomavirus DNA in cervical tissue. Retrospective analysis of 855 cervical biopsies. Arch Gynecol Obstet. 1997;259:69-77.
20. Dabic MM, Hlupic L, Babic D, et al. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffinembedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35:511-516. (Pubitemid 41043622)
21. Hopman AH, Theelen W, Hommelberg PP, et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006;210: 412-419. (Pubitemid 44830601)
22. Schneider A, Meinhardt G, Kirchmayr R, et al. Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization. Int J Gynecol Pathol. 1991;10:1-14.
23. Yokoyama M, Tsutsumi K, Pater A, et al. Human papillomavirus 18-immortalized endocervical cells with in vitro cytokeratin expression characteristics of adenocarcinoma. Obstet Gynecol. 1994;83: 197-204. (Pubitemid 24043288)
24. Tseng HH, Wang JS, Kan YY. Human papillomavirus detection in adenocarcinoma and adenosquamous carcinoma of the uterine cervix in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 1996; 57:47-53.
25. Murphy N, Heffron CC, King B, et al. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch. 2004;445: 610-615. (Pubitemid 40104536)
26. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8-15.
27. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol. 2004;28:160-167. (Pubitemid 38124723)
28. Nielsen GP, Stemmer-Rachamimov AO, Shaw J, et al. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest. 1999;79:1137-1143. (Pubitemid 29444545)
29. Nucci MR, Crum CP. Redefining early cervical neoplasia: recent progress. Adv Anat Pathol. 2007;14:1-10. (Pubitemid 46052176)
30. Iaconis L, Hyjek E, Ellenson LH, et al. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection. Arch Pathol Lab Med. 2007;131:1343-1349. (Pubitemid 47427587)
31. Pirog EC, Baergen RN, Soslow RA, et al. Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol. 2002;26:70-75.
32. Murphy N, Ring M, Heffron CC, et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol. 2005;58:525-534. (Pubitemid 40646875)
33. Sapino A, Marchio C, Senetta R, et al. Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch. 2006;449:288-396. (Pubitemid 44367968)
34. Fadare O, Reddy H, Wang J, et al. E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol. 2005;3:38. (Pubitemid 41529264)
35. Bibeau F, Boissiere-Michot F, Sabourin JC, et al. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Arch. 2006;449:281-287. (Pubitemid 44367967)